Psychedelics Psilera raises US$8.8M to fight dementia with non-psychoactive psilocybin drug The biotech is preparing for in-human trials with 'PSIL-006' next year Rowan DunneMay 29, 2026
Psychedelics Enveric Biosciences skyrockets on patent allowance for psychedelic-inspired molecules Lead drug candidate EB-301 is structurally similar to DMT Rowan DunneDecember 11, 2025